In this episode Mike Ward, head of the firm’s Life Sciences group, discusses the unique aspects of the health crisis on the science, with Jim Mullen; the regulatory framework, with Bethany Hills; the commercial transactions, with Matt Karlyn; and the privacy and data security considerations with Kristen Mathews.